Meditation technique brings peace of mind to breast cancer survivors

Share this article:

An intervention known as mindfulness-based stress reduction (MBSR) showed a trend toward improving psychological outcomes by reducing mood disturbance in women who had survived early-stage breast cancer.

MBSR incorporates meditation, yoga, and physical awareness. In a recent study reported in the Western Journal of Nursing Research (2011;33(8):993-995), nurse researchers at the University of Missouri–Columbia (MU) administered MBSR group sessions over a period of 8 to 10 weeks. During these sessions, the breast cancer survivors practiced meditation skills, discussed how bodies respond to stress, and learned coping techniques.

Compared with a control group that received no MBSR training, participants who learned MBSR experienced statistically significant reductions in blood pressure, heart rate, and respiratory rate; increased their mindfulness state, and experienced improvements in mood.

Although the effects of MBSR on reducing stress were statistically significant on the physiological outcome (morning cortisol) at the measurement after the intervention completion, this effect was not sustained at 1-month follow-up. Coinvestigator and MU professor of nursing Jane Armer recommended in a separate statement that patients practice mindfulness-based meditation every day or at least routinely to garner short- and long-term benefits.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Improved tyrosine kinase inhibitor (TKI) selectively activates in tumor tissue, minimizing side ...

A new strategy developed by an interdisciplinary team of researchers aims to reduce the side effects connected to use of tyrosine kinase inhibitors (TKIs).

Prior cancer exclusion criteria may stymie potential of lung cancer clinical trials

A history of prior cancer can exclude many individuals from participation in clinical trails related to lung cancer, even when the prior cancer is unlikely to interfere with treatment outcomes.

Better adherence to guidelines for safe handling of antineoplastic drugs is needed

Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.